Podcasts about Kahr

In another special episode dedicated to the how, what and why of memory, Gyles talks to his long-time friend and colleague Professor Brett Kahr. Professor Kahr is a practising psychotherapist and an expert on Sigmund Freud, the father of psychotherapy and the inventor of the "talking cure". In this fascinating conversation, Gyles and Prof. Kahr take a detailed look at the power of childhood memories, particularly traumatic ones, to effect our adult lives, and the benefits to be had from examining them and learning from them. Brett also tells Gyles about Freud himself, how he developed his ideas and how he escaped the Nazis and came to London. Gyles talks to Brett about some of the memories we've heard from our guests on Rosebud, and Brett talks about some of the common themes which come up in psychoanalysis - such as dreams and sex. This is a wide-ranging and thought-provoking conversation, we hope you enjoy it. Professor Kahr's book: Coffee with Freud, is available from major bookshops online. Learn more about your ad choices. Visit podcastchoices.com/adchoices

In hour 3 today Mark discusses the latest news with the regular roundtable crew. With Trumps election, the gungrabbers will now turn their attention to the states as they will have little ability to move any legislation at the federal level. Two examples are MI seeking to criminalize "colored" guns and TX seeing nearly 100 gun control bills proposed by Democrats. The impratnc4 of fighting at the state level now must be ramped up as the gun control zealots turn their resources back to the states.

Wie können Menschen vor Fluten geschützt werden? Der Forschungsverbund Klima-Anpassung, Hochwasser, Resilienz - kurz KAHR - berät heute darüber.in Wesseling bei Köln.

GOD Provides / JESUS SavesPatreon https://bit.ly/3jcLDuZServant MilitoBecome a supporter of this podcast: https://www.spreaker.com/podcast/gunfighter-life-survival-guns--4187306/support.

Joshua Kahr shares insights from his extensive experience in commercial real estate, particularly in multifamily investments. He discusses his current focus on value-add deals, the importance of understanding market cycles, and the challenges of staffing in the current labor market. Joshua emphasizes the opportunities available in mismanaged assets and the lessons learned from past market disruptions, including the impact of COVID-19. He concludes with thoughts on the future of real estate investing and how to connect with him.   Sponsors: Altra Running  

Dans cette deuxième partie de l'épisode avec Coline Kahr-Aunis, nous explorons son arrivée à Munich, une ville qui n'a pas immédiatement conquis son cœur. Enceinte de son premier enfant et après deux ans de relation à distance, elle quitte Marseille pour un nouveau départ en Allemagne. Elle partage avec nous les défis d'adaptation dans un nouvel environnement, mais aussi comment elle a su redéfinir son identité professionnelle. À travers la radio, le doublage et le théâtre, Coline découvre que sa voix peut devenir bien plus qu'un simple atout : c'est son véritable métier. Entre opportunités saisies et créations de nouveaux chemins, Coline nous montre comment la passion et la persévérance peuvent nous guider, même dans un pays étranger.Si tu es curieux de savoir comment elle a transformé les défis en opportunités à Munich, cet épisode est pour toi !Tu retrouveras toutes les notes de l'épisode dans l'article dédié sur le site dessinemoimunich.com. Pour envoyer un message et/ou suivre Colineson site internetson Instagraml'Instagram de l'émission de radio À-PROPOSson Linkedin Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

Andy Hooser sits in for Mark attending KAHR ARMS Rod Of Iron Festival

C'est la voix de l'émission À-PROPOS sur Radio Lora, elle foule régulièrement les planches des théâtres munichois et son timbre s'insinue également dans nos oreilles lors de la visite audioguidée de certains musées : Coline Kahr Aunis a fait de sa voix plus qu'un outil. C'est son métier et son médium pour transmettre des émotions, vivre des expériences et vulgariser des connaissances, le fil rouge de son parcours riche et sinueux.Véritable équilibriste caméléon (ou de manière plus exhaustive : tour à tour vulgarisatrice scientifique, médiatrice culturelle, responsable de pôle de communication digitale, actrice voix, comédienne, autrice, animatrice radio, improvisatrice), elle mis du temps avant de s'autoriser à faire de sa passion un métier. Et comme c'est souvent le cas dans ce podcast, Munich n'est pas étranger à l'histoire. Comment a-t-elle fait des différents chemins de traverse empruntés un carrefour qui lui permet aujourd'hui de valoriser ses compétences tout en vivant pleinement sa passion ?C'est l'objet de cet épisode en 2 parties. ---Les réseaux de ColineSon siteSon LinkedinSon InstagramSon actuColine joue du 14 au 30 novembre la magnifique pièce « Oublie-Moi ».

"Lütfun da Hoş Kahrın da Hoş" Bütün fırtınalar hayatınızı bozmak için gelmez, bazıları yolunuzu temizlemek için gelir der Paulo Coelho. Bu söz hayatımızı olumsuz olarak etkileyen olayların arkasında duran hikmetlerle ilgili yapacağımız sohbeti aydınlatıyor.Merhaba sevgili dostum ben Hasan Basri Budak bir Kendine Gel podcast'i daha seninle.Keyifli dinlemelerBecome a supporter of this podcast: https://www.spreaker.com/podcast/hasan-basri-budak-ile-kendine-gel--5728974/support.

Schon wieder Hochwasser. Ein Jahrhundertereignis, ebenfalls: Schon wieder. Oben auf der Welle schwimmt die Zukunftsfrage: Können wir uns eigentlich an ein neues Klima anpassen? Im Gespräch sind gleich zwei Experten für Hochwasser und Katastrophenmanagement. Holger Schüttrumpf leitet das Institut für Wasserbau an der RWTH Aachen, Jörn Birkmann das Institut für Raumordnung an der Universität Stuttgart. Beide gemeinsam begleiten im Projekt KAHR den Wiederaufbau an der Ahr. KAHR steht für Klima-Anpassung, Hochwasser-Resilienz. Und genau darum dreht sich dieser Podcast: Können wir aus Katastrophen lernen und uns anpassen? Und wenn ja, was bedeutet das?Holger und Jörn betonen: Wir brauchen differenzierte Sicherheit. Krankenhäuser und Feuerwehren müssen auch unter extremen Bedingungen möglichst lange funktionieren. Weg von der Hafenkante damit, oder gleich auf Stelzen. Und muss man das Umspannwerk unbedingt dorthin bauen, wo es zufällig gerade flach ist, also ins Flusstal? Die beiden sind sehr deutlich: Wir werden nicht jedes Eigenheim genauso schützen können. Zumal Sicherheit zu einem beweglichen Ziel wird. Wo ist denn nun HQ100 - also das Gebiet in dem wir statistisch einmal pro hundert Jahre mit Überschwemmung rechnen? Schätzen wir das in zehn Jahren anders ein? Und wo dokumentieren wir das eigentlich? Wir bräuchten so etwas wie einen Hochwasser-Pass. Jörn beklagt, dass wir zwar groß darin sind, Faltblätter zu erstellen, um Informationen breit zu streuen. Aber wenn es an die Baugenehmigung geht, dann spielen Katastrophenthemen keine Rolle mehr.Es ist trügerisch zu glauben, dass die Erfahrungen aus der Vergangenheit auch die Lösungen für die Zukunft bieten. Wir wissen im Grunde, wie resilient bauen geht. Wir tun es nur nicht. Dabei würden schon kleine Maßnahmen helfen. Keller einen Meter höher, ein paar Stufen oder eine Rampe zur Tür. Den Strom nicht in den Keller. Und die Ölheizung? Die ist insgesamt ein Problem: Schwimmt der Tank auf, wird das Haus zum Sondermüll, das Nachbarhaus meist auch und die Natur drum herum …Insgesamt sind wir langsam. Vor zehn Jahren wurde das Nationale Hochwasserschutzprogramm aufgelegt. 168 Maßnahmen. Davon sind genau neun umgesetzt und abgerechnet. Neun. Dabei lohnt sich Prävention, gerade finanziell. Anpassung war lange ein Thema, um das die Klimadiskussion einen Bogen gemacht hat. Niemand wollte den Eindruck erwecken, wir könnten uns weniger um Klimaschutz bemühen, weil wir uns ja anpassen könnten. Außerdem ginge die Anpassung doch vor allem kleine Inselstaaten in der Südsee etwas an. Inzwischen wissen wir: Wir brauchen beides: Klimaschutz und Anpassung. Das gilt gerade beim Wasser: Wir brauchen es und müssen uns zu gleich davor schützen.Beide sind sich im Fazit einig: An die großen Trends können wir uns anpassen. Also zum Beispiel die zunehmend ungleiche Verteilung der Niederschläge übers Jahr ausgleichen. Bei den Extremen geht das nicht, jedenfalls nicht zu 100%. Wir wissen nämlich nicht: Wie extrem kann ein Extrem werden? Wir haben technische Grenzwerte, die aber nichts darüber aussagen, ob dieser Grenzwert überschritten wird und wie oft. Wir müssen lernen, das zu akzeptieren: Wir können nicht alle Extreme abpudern. Wir können Todesopfer weitgehend vermeiden, aber Schäden? Nein. Dafür haben wir viel zu dicht und viel zu nah am Wasser gebaut.Zu Gast: Univ.-Prof. Dr.-Ing. Holger Schüttrumpf, Lehrstuhl und Institut für Wasserbau und Wasserwirtschaft (IWW) RWTH Aachen UniversityUniv.-Prof. Dr.-Ing. Jörn Birkmann, Institut für Raumordnung und Entwicklungsplanung (IREUS)...

GOD Provides JESUS SavesGoodShepherdTraining.comPatreonhttps://account.venmo.com/u/MilitoMinistryPodI'm Humbled by Your Support, Thanks and Have a Blessed DayServant MilitoBecome a supporter of this podcast: https://www.spreaker.com/podcast/gunfighter-life-survival-guns--4187306/support.

Professor Brett Kahr has worked in the mental health profession for well over forty years. He is Senior Fellow at the Tavistock Institute of Medical Psychology in London and, also, Visiting Professor of Psychoanalysis and Mental Health at Regent's University London. Kahr is the Chair of the Scholars Committee of the British Psychoanalytic Council, and he now works in full-time independent practice with individuals, couples, and families in Central London. A trained historian as well as a clinician, he is Honorary Fellow and, also, Honorary Director of Research at the Freud Museum London. He has authored nineteen books and has served as series editor of over eighty-five additional books.  His best-selling titles include Who's Been Sleeping in Your Head?:  The Secret World of Sexual Fantasies – described in The Observer newspaper as “The new Kinsey” – based on his research project about the erotic fantasies of over 30,000 British and American adults.  He has also produced many clinical books, such as Bombs in the Consulting Room:  Surviving Psychological Shrapnel, and, also, the very popular How to Flourish as a Psychotherapist. Sign up for 10% off of Shrink Rap Radio CE credits at the Zur Institute

Blue Notes in vielen Farben. Keepin‘ It Hot - Jim Kahr. Immer Freitags präsentieren wir an dieser Stelle alte und neue Aufnahmen aus den Bereichen Blues, Jazz, Swing, Rhythm'n'Blues, Soul und Country. (Sendung vom 26.4.24)

Drs. Shaalan Beg and Aparna Parikh discuss the role of ctDNA as a powerful prognostic biomarker for GI cancers, along with its impact on risk stratification and the detection of recurrence. They highlight key studies in ctDNA that were featured at the 2024 ASCO GI Cancers Symposium, including COBRA, GALAXY, and BESPOKE in CRC, as well as the promise of ctDNA testing in the preoperative detection of iCCA. TRANSCRIPT Dr. Shaalan Beg: Hello, and welcome to the ASCO Daily News Podcast. I am Dr. Shaalan Beg, your guest host for the ASCO Daily News Podcast today. I am an adjunct associate professor at UT Southwestern's Harold Simmons Comprehensive Cancer Center in Dallas. On today's episode, we will be discussing the emergence of circulating tumor DNA (ctDNA) technology in GI cancers. I am delighted to be joined by Dr. Aparna Parikh, an assistant professor of medicine at Harvard University and the director for colorectal medical oncology at the Massachusetts General Hospital Cancer Center, where she also serves as the medical director of the Young Adult Colorectal Cancer Center. Dr. Parikh will share her insights on key research on this hot topic in GI oncology that was featured at the recent ASCO Gastrointestinal Cancers Symposium.  Our full disclosures are available in the transcripts of this episode, and disclosures related to all episodes of the podcast are available at asco.org/DNpod.  Dr. Parikh, it's great to have you on the podcast today. Dr. Aparna Parikh: Thanks so much, Dr. Beg.  Dr. Shaalan Beg: In recent years, it has become evident that liquid biopsy and other emerging ctDNA technologies are changing how we treat GI cancers, and colorectal cancer (CRC) is in the forefront of this space. Before we dive into key studies, can you briefly highlight for our listeners how ctDNA is advancing the field and how it can influence the care that we deliver to our patients in the future? Dr. Aparna Parikh: Absolutely, ctDNA is certainly a hot topic. What we have learned over the years is that ctDNA has emerged across many solid tumor types as one of the most powerful, if not the most powerful, prognostic biomarker we have to date. ctDNA has improved risk stratification. We have learned a lot about the role in what is called minimal or molecular residual disease in patients with early-stage disease, and ctDNA being a biomarker of recurrence for those patients, with ctDNA, we have a better understanding of tumoral heterogeneity, both spatially and temporally, getting a better glimpse of what is happening in a given patient with multiple metastases, as well as genomic evolution of tumors over time. So certainly many, many roles and areas where ctDNA is emerging. Dr. Shaalan Beg: This was a hot topic at the 2024 ASCO GI Cancers Symposium, and we're going to take a deep dive into some of the abstracts that were presented. Let's start with the COBRA study, which is the NRG-GI005. That was Abstract 5 at the ASCO GI Cancers Symposium, and the GALAXY study, which was Abstract 6 at the symposium. So, the COBRA study reported results of ctDNA as a predictive biomarker in adjuvant chemotherapy for people with colon cancer. At a high level, it was a negative study, but there are some important lessons for us to learn. Similarly, in the GALAXY study, investigators from Japan presented an updated analysis on the correlation of ctDNA dynamics with outcomes in colorectal cancer with minimal residual disease. How do you synthesize all this information and help the listeners understand our current state for ctDNA applications in colorectal cancer? Dr. Aparna Parikh: Yeah. Let's take the COBRA study first. Let's talk a little bit about the design of COBRA. COBRA was intended to look at patients that were resected, stage 2 colorectal cancer patients, or colon cancer patients who were 2A. These are patients where the treating physician would, at the outset, decide that there was no adjuvant chemotherapy indicated. These are patients where active surveillance would be entirely appropriate as the standard of care. Patients were randomized to arm 1, which was active surveillance, or randomized to arm 2, which was assay-directed therapy. If there were ctDNA positive in arm 2, then they were given chemotherapy, FOLFOX or CAPOX. And if they were “ctDNA not detected,” then they would also go on to active surveillance.   And so, the plan was that nearly 1,500 patients are to be recruited, and at the time of this data cut, they had around 630-some patients. The primary objective was to look at the clearance rates of ctDNA between the ctDNA-positive cohorts, remember, the chemotherapy and the active surveillance cohorts at 6 months. They had around a 5% detection rate of ctDNA patients. Ultimately, that was around 16 patients. The reason that the study shut down was that what they found was that in the surveillance arm, the arm that was not getting any treatment, they had a ctDNA clearance of 43% versus 11% in the chemotherapy arm. They had an interim analysis to look at the clearance rate between the 2 arms, and what was surprising to the investigators and the community was what was happening in terms of clearance. Why do we have a 43% clearance rate in patients that were not getting anything? And so, because of that, the study was shut down as it did not meet its prespecified interim look at clearance in those 2 arms.   Many things came up in terms of learnings from COBRA. Number one was the characteristics of the assay. And so, you take an assay in a low-risk patient population that has a fixed specificity, and when your baseline prevalence of recurrence is so low, for example, in low-risk stage 2 patients, your composite predictive value is very susceptible to small changes in that specificity. And so, your PPV is going to be a lot lower in a low-risk patient population than a higher-risk patient population. The COBRA study used an older version of a tumor-uninformed assay, so it definitely called into question some characteristics of the assay. Is one-time-point clearance sufficient, and is that the right endpoint? We have seen now, including the GALAXY study that we'll talk about here, previously reported just spontaneous clearance happening in 5%, 10% of patients. The question with that spontaneous clearance is: Was it actually clearance, or was chemotherapy just perhaps in a low ctDNA shedding state? Are you just suppressing the ctDNA below the level of limited detection?  And then in this study, the clearance draw was actually done in the chemotherapy arm right before the last cycle of chemotherapy, again to that point of, are you just suppressing the ctDNA with chemotherapy? There is also stochastic sampling error that can happen in patients with very low residual tumor volume. So, I think this is a disappointing study in the sense that it is still a really important question. There are still 2A patients that recur, but maybe [this was] not the right test, or maybe single-time-point testing wasn't enough. And so, lots of lessons to be learned from this study in terms of test and design, but hopefully more to come. I think certainly stage 2 patients remain an area where I think, hopefully, ctDNA still plays a factor for those patients.  Dr. Shaalan Beg: And how was the patient population for the GALAXY study? That was Abstract 6, compared to the COBRA study. Could you summarize those findings for us?  Dr. Aparna Parikh: Yeah, so GALAXY was part of a large study in Japan that includes an observational cohort plus therapeutic cohorts as well. And so, GALAXY was just further reporting of the observational cohort. So unlike COBRA, which is a low-risk, stage 2 study that was actually asking that interventional question: Can you use it to guide therapy? The GALAXY and the updated GALAXY just continues to show more clinical validity data rather than clinical utility data. And it was nearly 3,000 patients, pan stages. Again, the lion's share were stage 2 and 3 patients, but there were also stage 1 and stage 4 patients as well. And what they showed was that ctDNA is undoubtedly prognostic. They showed very consistent Kaplan-Meier curves, which we've seen time and time again, where if you're ctDNA-positive, you don't do as well.  What they showed was, not surprisingly, with longer-term follow-up – this is 24-month follow up, so longer-term follow up than was published in their paper last year – was that when you test at one time point, so landmark testing, the sensitivity of detecting recurrence was around 48%, and that fell from the publication last year which was around 58%, 59%, which is not surprising as you follow more people. I think single time point testing soon after surgery may miss those late recurrences, but it's still prognostic and showed a specificity of around 94%.   They also continued to show that if you continued to test with serial testing, your sensitivity improves, but what was really interesting and new, what they presented this time, was a clearance analysis. And showing, again, comparable to COBRA, in many ways, in the sense that clearance can be a little bit finicky, especially at one time point, is what they showed is that patients who had sustained clearance, and these are patients that had at least two time points with their ctDNA remained to be negative, they did very well. But if you had transient clearance, and again, the definition was a little bit broad, at least having one negative and then one positive, those patients ultimately, at 24 months, the curves came together with the no clearance curve. So initially, they did better than the people that didn't have any clearance. But if you transiently cleared at two years, the curves came back together.   And what was interesting is that in those patients that sort of transiently clear by 9 to 12 months, 80% of those are actually having a rapid return of ctDNA. And so this begs the question of was chemotherapy just suppressing that ctDNA or maybe if you have a better test you could have actually improved it.  These were some of the updated, interesting learnings from GALAXY, which remains incredibly prognostic. And then the concept of clearance, which I think we have to look into a little bit more as a field, and understanding that maybe just one time point clearance isn't sufficient.  Dr. Shaalan Beg: Yeah, and one of the most important applications for ctDNA can be its ability to inform adjuvant chemotherapy. Its ability to not only identify more people who may benefit from chemotherapy, but maybe even identify people who don't need chemotherapy. And along those lines, Abstract 9, the BESPOKE study, looked to understand the role of ctDNA-based detection of molecular residual disease to inform adjuvant therapy for stage 2 and 3 colorectal cancer. And they presented interim data at the GI ASCO this year. What were your takeaways from this study? Dr. Aparna Parikh: Exactly. Beyond the prognostic implications, I think what was really interesting was that there was the initial data looking at the benefit of adjuvant chemotherapy. So, what they did was they said, “Okay. We're going to take the MRD-positive patients and look at the benefit of adjuvant chemotherapy and then the benefit of adjuvant chemotherapy in the MRD-negative patients.” And again, remember, this is a prospective observational study, so it's not looking at negative and positive to guide therapy, but it's just looking prospectively and observationally at how those patients are doing. But what they showed again is that indeed, in the adjuvant chemotherapy group, the benefit of adjuvant chemotherapy again with the follow-up to date on the study was different in the MRD-positive patients.  First of all, I guess taking a step back, the DFS in the ctDNA-negative patients at 2 years was very good. So negative patients had over 98% 2-year DFS in both the adjuvant chemotherapy and observational group. And there was no real difference between adjuvant or not. But in the positive patients, not surprisingly, the DFS was worse. But what was reassuring to see is that you can make an impact with adjuvant chemotherapy in the positive patients. And the difference in DFS between the positive and negative patients, with adjuvant or not, was 42% versus 12.5%, in the observational patients. So, it is benefitting the patients who are positive so it does give us more data that, again, at least in the positive patients, you may be able to reverse the recurrences there with adjuvant chemotherapy. And maybe if you're negative, eventually, we'll get to a point of de-escalation of care. Again, keeping in mind the kinds of sensitivity limitations as well.  Dr. Shaalan Beg: Wonderful. And one of the other malignancies in the GI space where precision therapies and molecular biomarkers are making a huge difference are intrahepatic cholangiocarcinoma. Genomic profiling using ctDNA is increasingly being used in this population to inform precision oncology approaches and determine mechanisms of resistance to targeted therapies as well. In Abstract 528, investigators looked at the role of preoperative ctDNA testing for resectable intrahepatic cholangiocarcinoma. What are your thoughts on that study?  Dr. Aparna Parikh: Yeah, it's such an important area, as you mentioned, in the metastatic space – FGFR, IDH1, all these alterations that are emerging in intrahepatic cholangios. This was a very small study, it was preoperative, and so the tumor was intact, and around 14 patients. They used a tumor-informed approach just for detection and quantification of ctDNA. So this was not a study that was looking at a next-generation sequencing approach where you're going to actually be able to detect the alterations, but it's actually looking for the detection and quantification of ctDNA rather than genomic characterizations. And patients had about a month or so where they had their baseline blood detected. And I think what was reassuring to say was that ctDNA was actually detected in all the patients with the primary tumor intact, except for one patient who was a very low-risk stage 1A patient. There was some correlation, against a small number of patients, between the concentration of ctDNA in patients that had the lower stage and then the higher stage groups. Small numbers were actually hard to characterize and correlate with recurrence or mortality, but at least, some correlation with pathologic tumor size, they were able to because it was a bespoke panel and you're sampling the tissue and then looking in the blood, IDH1 and 2 were mutations that were tracked based on the genomic profiling and a couple of the patients were able to have their IDH mutations tracked.  So it gives us a sense, a little bit, that ctDNA, we know has a lot of variable shedding across disease states and tumor locations, but gives us some promise that it is reliably detected with the tumor-informed approach, at least preoperatively in cholangios. So may again open some more opportunities for MRD testing in cholangiocarcinoma as well.  Dr. Shaalan Beg: Thank you. That's a wonderful review of ctDNA applications in gastrointestinal cancers from the 2024 ASCO GI Cancers Symposium. Thank you, Dr. Parikh, for sharing your valuable insights with us on the podcast today. Dr. Aparna Parikh: Thank you so much for having me. Dr. Shaalan Beg: Thank you to our listeners for your time today. You'll find links to the abstracts discussed today in the transcript of this episode. Finally, if you value the insights that you hear on the ASCO Daily News Podcast, please take a moment to rate, review, and subscribe wherever you get your podcasts.   Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.   Find out more about today's speakers: Dr. Shaalan Beg @ShaalanBeg Dr. Aparna Parikh @aparna1024   Follow ASCO on social media:  @ASCO on Twitter  ASCO on Facebook  ASCO on LinkedIn    Disclosures: Dr. Shaalan Beg: Employment: Science 37 Consulting or Advisory Role: Ipsen, Array BioPharma, AstraZeneca/MedImmune, Cancer Commons, Legend Biotech, Foundation Medicine Research Funding (Inst.): Bristol-Myers Squibb, AstraZeneca/MedImmune, Merck Serono, Five Prime Therapeutics, MedImmune, Genentech, Immunesensor, Tolero Pharmaceuticals   Dr. Aparna Parikh: Consulting or Advisory Role (An Immediate Family Member): PMV Consulting or Advisory Role: Checkmate Pharmaceuticals, Guardant Health, Foundation Medicine, Abbvie, Value Analytics Labs, Bayer, Taiho Oncology, Delcath, Seagen, CVS, SAGA Diagnostics, Scarce, Illumina, UpToDate, Takeda, AstraZeneca, Takeda, Pfizer, Kahr, Xilio Therapeutics, Sirtex Research Funding: PMV Pharma, Erasca, Inc, Syndax Research Funding (Institution): Bristol-Myers Squibb, Genentech, Guardant Health, Array, Eli Lilly, Novartis Pharmaceuticals UK Ltd., PureTech, Mirati Therapeutics, Daiichi Sankyo, Karkinos Other Relationship: C2i Genomics, Xgenomes, Parithera, Cadex

Juhhuuu!!! Wir sind in Graz!! Lange hat sich das Team rund um Krauli und Günther darauf gefreut, mit dem mobilen Studio nach Graz zu ziehen - in dieser Stadt herrscht ein toller und gemeinschaftlicher Rhythmus. In der entstandenen Episode 11 hat es Günther Lainer geschafft, die Ausnahmepolitikerin Elke Kahr in die Sendung einzuladen. Sie spricht in dieser Ausgabe von "beim Gast zu Gast" über die Stadt Graz, von karikativen Unternehmungen, die Stadtentwicklung und über ganz ganz viele andere tolle Dinge. Die beiden Hosts haben es auch wieder geschafft, alle Fixpunkte wie Gastgeschenke, Aktionen usw. in die Sendung einzubauen. Wir finden es ist eine tolle und erfrischend erste Sendung aus Graz, viel Spaß damit! Ab sofort ist dieser Podgast auch visuell zu genießen, in voller Länge auf YouTube: Feedback: deinsenf@beimgast.atGast: Elke KahrStadt: GrazHost: Christoph Krauli Held & Günther Lainer

Am 26. Februar 1924 war es soweit: Vor dem bayerischen Volksgericht beim Landgericht München I begann der Hochverratsprozess gegen Adolf Hitler, Erich Ludendorff und acht Mitangeklagte wegen des versuchten Staatsstreiches gegen die Republik vom 9. November des vergangenen Jahres. Nicht angeklagt wurden der bayerische Generalstaatskommissar Gustav von Kahr, der Landeskommandant der Reichswehr in Bayern Otto von Lossow und der Chef der Bayerischen Landespolizei Hans von Seißer, die in die Putschpläne ursprünglich eingeweiht, in dessen Verlauf jedoch abgesprungen waren. Ihre Rolle war es jedoch, die an den ersten Prozesstagen im Mittelpunkt der Verhandlungen stand; wobei die überforderten oder unwilligen Laienrichter es zuließen, dass Hitler und seine Mitstreiter diese „Zeugen“ teilweise von der Anklagebank aus selbst in der Art von Anklägern verhörten. Der Gerichtsreport des Berliner Tageblattes vom 27. Februar konzentriert sich dabei vornehmlich auf die Aussagen des Angeklagten Friedrich Weber, der sich als Leiter eines Freiwilligenkorps am Hitlerputsch beteiligt hatte. Es liest Frank Riede.

Würde sich die Republik diesmal als wehrhaft erweisen oder ihr der in großen Teilen illoyale, weil aus der Kaiserzeit übernommene Justizapparat wieder in den Rücken fallen? Die Spannung vor dem Prozess gegen die Putschisten vom 9. November 1923 war groß, und die Presse brachte sich bereits Wochen vor dessen Auftakt in Position. Aus der zuverlässig republikanischen Berliner Volks-Zeitung vom 6. Februar 1924 erfahren wir, dass man in den rechten Blättern wohl vor allem versuchte, für die Person Ludendorffs Stimmung zu machen und nichts unversucht ließ, Einfluss auf das Gericht in seiner Angelegenheit, aber auch in der des bayerischen Generalstaatskommissars Gustav von Kahr und der des Landeskommandanten der Reichswehr in Bayern Otto von Lossow auszuüben. Letztere wurden tatsächlich beide nur als Zeugen geladen und Ludendorff als einziger Angeklagter schließlich freigesprochen – ein Schelm, wer Böses dabei denkt. Es liest Paula Rosa Leu.

Sendung vom 01.02.2024

Making a Scene Presents the PODCAST of LIVE from the Midnight Circus Featuring Jim KahrThis is the Voice of Indie Blues, the future of the blues. Artists who embrace the diversity of the blues that always has and still is being created from it's roots. These artists understand the blues is a living art form that is driven by innovation and creativity. These are the Indie Blues Artists!Honoring the Past, Praising the Present, Empowering the Future http://www.makingascene.org

Making a Scene Brings you an interview with Jim KahrJIM KAHR…. vocalist / guitarist / composer / mandolin.  Born & bred in Chicago with deep embedded roots in the "Chitown"  music scene. He quickly became a respected fixture around town.  JK toured and recorded with several icon legendary artists over decades of international performing. http://www.makingascene.org

Die bekanntlich sehr milden strafrechtlichen Konsequenzen für die Beteiligten des Hitler-Ludendorff-Putsches wurden in einem Prozess ab dem 26. Februar 1924 festgelegt. Das juristische Vorspiel zu diesem Prozess begann allerdings unmittelbar nach dem Putsch. Die Staatsanwaltschaft sprach mit den Rechtsbeiständen der Festgesetzten und bereitete den Prozess vor. Ein Ziel der Untersuchungen war es, Licht in die Vorgeschichte des Putsches zu bringen. Gerade die Frage, wie sehr Hitler v. Kahr und Lossow gezwungen hatte mitzumachen, bzw. inwieweit diese im Vorfeld dem Putsch zugestimmt hatten, stand im Vordergrund. Das Berliner Tageblatt druckte am 10. Dezember 1923 die Ausführungen von Hitlers Anwalt, Lorenz Roder, ab, zusammen mit den Kommentaren des Generalstaatskommissariats. Egal was genau abgesprochen war zwischen v. Kahr, Lossow, Ludendorff und Hitler, ganz deutlich ist, dass alle ganz offen einen politischen Umsturz planten, lediglich in den Mitteln und im Timing gab es zwischen ihnen Differenzen. Für uns begibt sich Frank Riede in das juristische Klein-Klein von Aussage gegen Aussage.

Treue Hörer:innen von Auf den Tag genau haben nicht nur gehört wie stark diverse Machtzirkel in Bayern antirepublikanisch und separatistisch zu agieren trachteten und tatsächlich agierten. Unser Podcast hat auch dokumentiert wie seit dem „Marsch auf Rom“ Benito Mussolinis Adolf Hitler und die NSDAP in den Fokus der Berliner Hauptstadtpresse gerieten. Seine Putschpläne äußerte er unverhohlen und auch, dass ein Umsturz mit einem „Marsch auf Berlin“ von München aus beginnen sollte. Am Abend des 8. November 1923 stürmte die NSDAP eine Veranstaltung im Bürgerbräukeller und verkündete eine neue nationale Regierung. Dass der Landeskommandant der Reichswehr in Bayern Otto von Lossow und der Regierungspräsident von Oberbayern Gustav von Kahr ihre Unterstützung für Hitlers und Ludendorffs Staatsstreich sofort wieder entzogen, sobald sie aus dem Bürgerbräukeller herausgekommen waren und gegen den Putsch agierten, war ein wichtiger Faktor dafür, dass der Putsch schnell scheiterte. Zumindest verkündeten die meisten Berliner Zeitungen in ihren Abendausgaben vom 9. November bereits die Niederschlagung des Aufstandes. So auch der Berliner Börsen-Courier. Welchen Überblick über die unübersichtliche Lage in München er denjenigen gab, die neugierig genug waren, um 30 Milliarden Mark für die Ausgabe zu zahlen, liest für uns Paula Rosa Leu.

Bu video 04/03/2018 tarihinde yayınlanan " MUSİBETLERİN EKŞİ ÇEHRESİ VE HİKMETİN GÜZEL YÜZÜ" isimli bamtelinden alınmıştır. Yayının tamamını buradan izleyebilirsiniz :http://herkul.org/bamteli/bamteli-mus.... Bela ve musibetler, dış yüzleri itibarıyla çirkin, sevimsiz, iç bulandırıcı ve aynı zamanda insanın nöronlarına, Hipofiz bezine, Talamus bezine gelip çarpan şeytanî şerâreler mahiyetinde duyulur, hissedilir. Fakat meselenin sonucuna/neticesine bakmak lazımdır. Bu bakış açısı da aslında size, bize ait değildir, Kur'ân'ın fermanıdır: وَعَسَى أَنْ تَكْرَهُوا شَيْئًا وَهُوَ خَيْرٌ لَكُمْ وَعَسَى أَنْ تُحِبُّوا شَيْئًا وَهُوَ شَرٌّ لَكُمْ “Olur ki, siz bir şeyden hoşlanmazsınız da o şey hakkınızda hayırlıdır; bir şeyi seversiniz ama o şey de hakkınızda şerlidir.” (Bakara, 2/216) Mesela, i'lâ-i Kelimetullah istikametinde çekilen çileler.. o mevzuda bir yönüyle duygu-düşünce açısından kıvamın önemli bir unsuru olan manevî cihadlar, mücahedeler, manevî savaşlar.. Allah Rasûlü'nün (sallallâhu aleyhi ve sellem) “cihâd-ı ekber” dediği şey… Antrparantez arz edeyim: “Günümüzde maddî kılıç, kınına girmiştir; Kur'an'ın elmas düsturları, elmas prensipleri hükümfermadır.” Küreselleşen bir dünyada o türlü şeylere gitmek, katliamlara sebebiyet verir, ardı arkası kesilmeyen savaşlar fâsid dairesine sebebiyet verir, vuruşmalar kısır döngüsüne sebebiyet verir. Hele günümüzdeki o korkunç silahlarla?!. 1945'lerdeki, 50'lerdeki Japonya'nın başına patlayan silahlar değil; bunlar, bugün bir yerde patladığı zaman, Amerika'nın yarısını alıp götürecek kadar korkunç silahlar!.. Bir Batılı düşünürün dediği gibi: “Bir üçüncü cihan savaşında, maktûl mezara, kâtil de yoğun bakıma kalkar!” Şimdi buna karşı sizin kalkanınız, sütreniz, siperiniz, insanî değerleri öne çıkarma, sevgiyi öne çıkarma, kucaklaşmayı öne çıkarma olmuştur/olmalıdır. Burada bir şey soracağım, vicdanlarınızla cevap verin: Sizler ve sizin arkadaşlarınız dünyanın değişik yerlerine açılırken, bunun (sevgi, kucaklaşma ve insanî değerlerin) dışında ne götürdünüz? Efendim, “Biz renk körüyüz!” dediniz. Efendim, “Duyma sağırıyız!” dediniz. Dolayısıyla elin-âlemin değişik anlayışsızlıklarına karşı, anlayışlı davrandınız. Duymaları gerekli olan “mesmûât”ın yanında farklı duyuşları duyucu oldunuz. Elin-âlemin farklı dil kullanmasına karşılık, siz, gönülleri yumuşatacak bir dil kullandınız. Kalbiniz gül gibi oldu; gezdiğiniz caddeler, sokaklar, çarşı-pazar da ıtriyat çarşısına döndü. Bağırlarını açtılar. Size yol verdikleri zaman da eşrârın şerrinden emniyet adına yol verdiler: “Gidin, koruyamayacağız sizi!” dediler ama zannediyorum yüreklerine kan damlıyordu. Evet, bir gün şartlar/konjonktür müsait olduğu zaman dönüp gideceğinizi/geleceğinizi bekleme sevdası ile zannediyorum bir intizar içindeler şu anda da. İnşaallah, Cenâb-ı Hak, o günleri de gösterir; eşrârın er geç akîm kalacak o hâinâne gayretlerini, sa'ylerini, himmetlerini akîm bırakır, inşaallah teâlâ. Evet, bazen dış yüzü itibarıyla, kabuğu itibarıyla çirkin görünen şeyler vardır; fakat iç yüzü itibarıyla çok lâtiftir. Başta, konuya başlarken, Alvar İmamı'nın sözüyle ifade ettik: Seyyidinâ Hazreti Âdem'in yaşadığı, bir zelle idi. Bir zelle idi ki, ثُمَّ اجْتَبَاهُ رَبُّهُ فَتَابَ عَلَيْهِ وَهَدَى “Ama sonra Rabbisi O'nu seçti de, tevbesini kabul buyurdu ve O'nu hidayetine mazhar kıldı.” (Tâhâ, 20/122) Sonra Allah, onu seçti, seçkinlerden yaptı ve arkadan gelen nesiller “Mustafeyne'l-Ahyâr”dan saydılar. Ne dediler? “Âdem, Safiyyullah!” dediler. “Hakikî şecerenin hikmeti / Dünyaya gele Muhammed Hazreti.” Hazreti Âdem, Cennet gibi bir güzellikler otağından ayrıldı fakat bir yönüyle, o otağa insanlığı çağırabilecek, Hazreti Rûh u Seyyidi'l-Enâm gibi bir “İnsan”a baba olma şerefi ile taçlandırıldı. ثُمَّ اجْتَبَاهُ رَبُّهُ فَتَابَ عَلَيْهِ وَهَدَى Cenâb-ı Hak, öyle eylesin, inşaallah!..

Bu simada yalan yok!..” *Allah Rasûlü'nün (sallallâhu aleyhi ve sellem) her tavrında Hak nümâyandı. Bakışlarında, kulak kabartışında, ağzını açışında, dilini ve dudaklarını hareket ettirişinde dahi hep Allah'a inanmışlığın hakikatleri görülürdü. Bir şair, O'nun halini, كُلَّمَا سَجَدَ تَجَلَّي اللهُ فِيهِ “Her secde ettiğinde onda Allah mütecelli olurdu.” sözleriyle ifade etmiştir. Yani O'na bakan bir insan, O'nun silinip gitmesi karşısında adeta Allah'la karşı karşıya kalıyordu. Hâşâ bunun manası, zat-ı nübüvvette, Zat-ı Ulûhiyet tasavvur etme değildir. Bilakis O'nun her tavır ve davranışıyla Allah'ı ifade ettiğini vurgulamaktır. Dolayısıyla böyle bir Nebiyy-i Muhterem'in huzurunda bulunan sahabîler hiç şüphesiz ayrı bir insibağ yaşıyorlar; neye nasıl teveccüh etmeleri gerektiğini çok iyi belirleyip hayatlarını o çizgide sürdürüyorlar ve bu halleriyle sonraki nesillere de hüsn-ü misal oluyorlardı. *İnsanlığın İftihar Tablosu'nun siması ve ahvâli öyle inandırıcıydı ki, Abdullah İbni Selâm Hazretleri, Peygamber Efendimiz'in huzuruna gelince, sadece O'na bakmış ve başka bir şey arama lüzumu hissetmeden, “Bu simada yalan yok.” deyip kelime-i şehâdet getirerek İslam'a dehalet etmişti. Öbür taraf aydınlıklar aydınlığı bir dünya; burası ise, görenler için fevkalade loş!.. *Öyle bir rehberin rehnümâlığı arkasında, öyle gayeler üstü bir gayeye ulaşma yolunda bulunanlar, onun karşılığında dünya sultanlığı bile olsa, ona dönüp bakmamalılar. Çünkü Aksaraylar, kara saraylar, Yıldızlar, Çırağanlar, Dolmabahçeler ve diğerleri O'nun teveccühünün gölgesinin gölgesinin gölgesinin… gölgesi yanında sadece sineğin kanadı gibi kalırlar. *“Sineğin kanadı” sözü şu hadisi hatırlattı: “Şayet dünyanın Cenâb-ı Hak nezdinde bir sinek kanadı kadar kıymeti olsaydı, kâfirler ondan bir yudum su bile içemezlerdi.” *Dünyanın kıymeti, Cenâb-ı Hakk'ın isimlerinin bir aynası ve ahiretin tarlası olmasındadır. Gerisi boş!.. Öbür taraf aydınlıklar aydınlığı bir dünya; burası ise, görenler için fevkalade loş. Eğer o Rehber-i pişuvânın projektörü altında yol almaya bakmazsanız, bu loş dünyada yürüyeceğiniz yolu şaşırırsınız; Allah muhafaza, düz yolda şaşkınlığa düşer ve dökülür yollarda kalırsınız. Beklentisizlik, insanın yükünü hafifletir *Beklentisizlik, insanın yükünü azaltır. Celâl ve cemâli bir görmek, yükü hafifletir. Yunus'un ifadesiyle, “Gelse Celâlinden cefa / Yahut Cemâlinden vefa / İkisi de cana safa.. / Lütfun da hoş, kahrın da hoş…” Cenâb-ı Hak lütfettiği zaman, metafizik gerilimle gerilirsin; “Oh be, elhamdülillah!” der, şükre vesile olacak davranışlarına yenilerini ekler ve “Birkaç sarp yokuş daha aşmalıyım!” düşüncesiyle yola koyulursun. Kahrı da gördüğünde, “Galiba bazı imkanları rantabl değerlendirmediğimden dolayı şefkat tokadıyla kulağım çekiliyor!” diye düşünürsün; “Dikkatli ol, sen burada misafirsin, burası senin evin değil; misafir, bir yerde mukim gibi davranamaz!..” tembihini almış gibi olursun. *Hâsılı, şu fâni dünyaya aldanmamalı. Aziz Mahmud Hüdâî hazretleri ne hoş söyler: “Yalancı dünyâya aldanma yâhû / Bu dernek dağılır dîvân eğlenmez / İki kapılı bir virânedir bu / Bunda konan göçer, konuk eğlenmez.” Alvarlı Efe Hazretleri de şöyle der: “Acib bir karûbân hane bu dünya / Gelen gider konan göçer bu elden / Vefası yok sefası yok fani hülya / Gelen gider konan göçer bu elden.” Bu video 09/08/2015 tarihinde yayınlanan “Sen Tohum At Git” isimli bamtelinden alınmıştır. Tamamı burada:https://www.herkul.org/bamteli/bamtel...

Ihr Wahlsieg hat international für Aufsehen gesorgt: Seit November 2021 ist die Kommunistin Elke Kahr Bürgermeisterin im österreichischen Graz. Was können Linke in Deutschland und Europa von dem Erfolg der KPÖ lernen? Ein Gespräch über Integrität, kommunistisches Regieren und Inseln des Widerstands.

Merriam-Webster's Word of the Day for August 3, 2023 is: incarcerate • in-KAHR-suh-rayt • verb To incarcerate someone is to put them in prison or, figuratively, to subject them to confinement, as in “people incarcerated in their obsessions.” // Because the accused man did not present a serious threat to society, many questioned the judge's order that he remain incarcerated while awaiting trial. See the entry > Examples: “[Attorney] Ray Taseff points to ‘the inhumanity of taking people off the streets who are not committing a crime but are merely asking for help and incarcerating them as a means of social control.' Instead of trying to ostracize people experiencing homelessness, cities should offer resources to help them break the cycle of poverty, get back on their feet and find long-term housing.” — Katherine Murray et al., The Miami Herald, 13 June 2023 Did you know? Just as English is full of nouns referring to places where prisoners are confined, from the familiar (jail and prison) to the obscure (calaboose and bridewell), so we have multiple verbs for the action of putting people behind bars. Some words can be used as both nouns and verbs, if in slightly different forms: one can be jailed in a jail, imprisoned in a prison, locked up in a lockup, or even jugged in a jug. Incarcerate does not have such a noun equivalent in English—incarceration refers to the state of confinement rather than a physical structure—but it comes ultimately from the Latin noun carcer, meaning “prison.” Incarcerate is also on the formal end of the spectrum when it comes to words related to the law and criminal justice, meaning you are more likely to read or hear about someone incarcerated in a penitentiary or detention center than in the pokey or hoosegow.

Thu, 16 Feb 2023 03:00:00 +0000 https://geschichteeuropas.podigee.io/164-164 9afff88f4b780db7cf7461f992855dab R: Zwischenkriegszeit Dies ist eine Auftragsproduktion des C.H. Beck Verlags Wolfgang Niess, "Der Hitlerputsch 1923: Geschichte eines Hochverrats", bei C.H. Beck erhältlich Verknüpfte Folgen Der Aufstieg Mussolinis und der Marsch auf Rom (1922), mit Dr. René Möhrle (31.10.2022) Die Ruhrbesetzung (1923-1925), mit Prof. Dr. Stefan Goch (09.01.2023) Hitlers Machtübernahme (1933), mit Andreas Mix (30.01.2023) Plakat des Hitlerputsches (1923) (09.02.2023) Zum Podcast UNTERSTÜTZE DEN PODCAST BEI STEADY! Podcast-Blog mit Kommentarfunktion #historytelling - Netzwerk unabhängiger Geschichtspodcasts Schick mir Kommentare und Feedback als Email! Der Podcast bei Fyyd Der Podcast auf Twitter schwarze0fm auf Twitter Frag mich nach deiner persönlichen Einladung ins schwarze0-Discord! Die Episoden werden thematisch und nicht nach Erscheinungsdatum nummeriert. Für einen chronologischen Durchgang zur europäischen Geschichte sollten die Episoden nach Namen sortiert werden. schwarze0fm hatte als Hobbyprojekt begonnen - inzwischen habe ich aber durch Auftragsproduktionen und Crowdfunding die Möglichkeit gewonnen, mehr und bessere Folgen für Geschichte Europas zu produzieren. Das Prinzip "schwarze Null" bleibt - die Einnahmen werden verwendet, für mich Rahmenbedingungen zu schaffen, den Podcast zu betreiben und weiterzuentwickeln. In dieser Folge habe ich das ausführlich erklärt. This episode of "Geschichte Europas" by schwarze0fm (Tobias Jakobi) first published 2023-02-16. CC-BY 4.0: You are free to share and adapt this work even for commercial use as long as you attribute the original creator and indicate changes to the original. 164 full R: Zwischenkriegszeit no Deutschland,Neuere und neueste Geschichte,Hitlerputsch,Nationalsozialismus,München,Adolf Hitler,Erich Ludendorff,Gustav Ritter v. Kahr,Hans v. Seisser,Otto v. Lossow Tobias Jakobi

Footloose in Munich, Harvard-educated Putzi Hanfstaengl finds himself drawn in by Hitler's charisma, quickly becoming one of his entourage, partly thanks to his enthusiastic piano-playing. But with the whole country in the grip of hyperinflation - pushing wheelbarrows of money to pay for a single loaf of bread - there is a call for a more drastic step: a coup against the federal government. Are the Nazis ready? Can they wait any longer? Starring Corey Johnson as Putzi Hanfstaengl, Tom Mothersdale as Adolf Hitler and featuring Michael Moloney as Gustav von Kahr, Bavarian State Commissioner. Cast: Putzi Hanfastaengl - COREY JOHNSON Adolf Hitler - TOM MOTHERSDALE Ernst Röhm - JOSEPH ALESSI Emil Maurice - OSCAR BATTERHAM Leni Hanfstaengl - MELODY GROVE Herman Göring - SCOTT KARIM Gustav Ritter von Kahr - MICHAEL MALONEY Ulrich Graf - FORBES MASSON General Ludendorff - ANDREW WOODALL Other parts were played by: EDWARD BENNETT, WILLIAM CHUBB, NICHOLAS FARRELL, GEORGE KEMP, SORCHA KENNEDY, JACK LASKEY and LYNNE MILLER The Narrator is JULIET STEVENSON Sound designer – ADAM WOODHAMS Studio Manager – MARK SMITH Casting Director – GINNY SCHILLER Original Score – METAPHOR MUSIC Writer and Director – JONATHAN MYERSON Producer – NICHOLAS NEWTON A Promenade Production for BBC Radio 4 and BBC Sounds

Die Nachwirkungen von Weihnachten und Silvester sind spürbar. Die dritte Staffel MDMNB startet und wir freuen uns auf ein wundervolles Kahr mit euch!

Kahr Arms initially defined the single stack 9mm concealed carry pistol. But in a world where every company has at least one gun in the micro-9mm carry niche, how does the venerable Kahr compare? MichaelBane.TV - On the Radio episode # 149. Scroll down for reference links on topics discussed in this episode. Disclaimer: The statements and opinions expressed here are our own and may not represent those of the companies we represent or any entities affiliated to it. Host: Michael Bane Producer: Flying Dragon Ltd. More information and reference links: Kahr Arms History of Kahr Arms Kahr Arms — Steering It's Own Market/Jeff Johnson, American Rifleman “Little Bitty Bushnells on Little Bitty Kahrs”/MB C&S Kahr PM9 Custom The Music of Hawkins The Music of Brooklyn Classical

Jörn Birkmann und Holger Schüttrumpf koordinieren ein Projekt des Bundesforschungsministeriums zur wissenschaftlichen Begleitung des Wiederaufbaus nach der 2021er Flutkatastrophe. Sein Name: "Klima Anpassung Hochwasser (und) Resilienz"

Thema: Seit einem Jahr regieren die Kommunisten in Österreichs zweitgrößter Stadt. Wie hat sich Graz seither verändert? Und wie hält es die KPÖ-Bürgermeisterin mit den Sanktionen gegen Russland?

Come hang out in our Discord server! https://discord.gg/mmksNZmgk9 Welcome back to episode 2 of Behind the Pencil. This week we are joined by Gerald Von Kahr from the Breakneck Fantasy Anthology! We discuss what it takes to organize and distribute a comic anthology and what books we're currently reading. Follow Gerald @GVonKahr Gollow Breakneck Fantasy Anthology @BreakNeckAnth And make sure to support and follow them on Kickstarter https://www.kickstarter.com/projects/breakneck-01/breakneck-fantasy-anthology-1-bandw-sword-n-sorcery-comics Follow the show @BDEPod And follow me @MikeyTabletop

Merriam-Webster's Word of the Day for August 13, 2022 is: carceral • KAHR-suh-rul • adjective Carceral means "of, relating to, or suggesting a jail or prison." // The room was eerily quiet and had a carceral aesthetic. // Her article stressed the importance of rehabilitative measures in carceral institutions, such as career preparation and mental health support. See the entry > Examples: "Coordinate care inside and outside carceral settings." — Bill Frist, Forbes, 15 June 2022 Did you know? Carceral is a member of a small but imposing family: like its close relations incarcerate (meaning "to imprison") and incarceration (meaning "confinement in a jail or prison"), its ultimate source is the Latin word for "prison," carcer. All three words have been in use since the 16th century, and all three are more common today than they were a century ago. Carceral has always been the rarest of the group, but its use has increased significantly since the turn of the current century, most often within academic or legal contexts.

Am 26. September 2021 ist die KPÖ mit 28,8% zur stärksten Kraft in Graz, der zweit-größten Stadt Österreichs gewählt worden und stellt seitdem mit Elke Kahr die Bürgermeisterin in einer Koalition mit den Grünen und der SPÖ. 9 Monate sind seit der Angelobung vergangen. In der Podcastfolge diskutiert Teresa mit Elke Kahr über die kleinen und großen Fragen des politischen Alltags. Was heißt es kommunistische Lokalpolitik in Graz zu machen? Wie kann man die großen Fragen der politischen Veränderung mit den Alltagsproblemen der Menschen verbinden? Braucht es dazu Reform, Revolution, Vergesellschaftung oder ein bisschen vor allem?

This episode of Techtalk features Tamar Raz, CEO at Hadasit Medical Research Services & Development, the technology transfer company of Hadassah University Hospitals in Jerusalem, and a Technology Transfer Expert with nearly 20 years of experience leading business transactions and management in the biotech and life sciences sector. Tamar is also the Director of KAHR-medical Ltd. and she serves as the chairperson of Hadasit Bio Holdings, a public holding company allowing public participation in the promising field of biotechnology. This conversation covers Tamar's point of view about the technology transfer in Israel and her remarkable experience as an expert and entrepreneur who brings medical innovations from the laboratory to the market. Tamar starts with an historical overview of the technology transfer sector in Israel and continues by giving us precious insights about the technology transfer infrastructure, steps, phases and key departments. We discuss not only the basics of technology transfer, but also more advanced industry activities like the incubation or acceleration programmes, that can not exist without the infrastructure described before. IBM Alpha Zone - the first accelerator that IBM built in the world, located in Israel - is a great example. Moreover, Tamar shares lessons about how a technology transfer center like Hadasit can become financially sustainable and the importance of a flexible business model that means long-term investment and short-term activities that bring revenues. “We worked in Hadassah, in the last 4 or 5 years, to enlarge the innovation ecosystem of Hadassah. So, we want to bring companies to work with us not only based on our IP, but also based on their IP, on their ideas. Because we believe that connecting the physicians and professors of Hadasa to the industry and to the start-up companies, we create a cycle of innovation at Hadassah that will bring us more work and will bring us more revenues. But also we create better inventors that will think about the new ideas all the time”, Tamar explains. Tune in to find Tamar's favorite Hadasit success story and:

In his latest book Freud's Pandemics: Surviving Global War, Spanish Flu, and the Nazis (Confer Books, 2021), Professor Brett Kahr has used his remarkable skills as experienced psychotherapist and rigorous historian to tell a meticulously researched, deeply engaging tale of the trials and tribulations of Sigmund Freud's life. Kahr has taken an unflinching look at the darkest hours of this remarkable man, such as the Spanish flu of 1918, the Nazi invasion of Austria in 1938 and a long struggle with carcinoma in later life. Digging deep into the archives, he has unearthed a treasure trove of stories that lets us appreciate Sigmund Freud`s genius even more against the backdrop of his struggle for survival. He has synthesized his findings in elegant prose to offer us an inspiring story of hope, most pertinent for our troubled times. Sebastian Thrul is a psychiatrist and psychoanalyst in training in Germany and Switzerland. He can be reached at sebastian.thrul@gmx.de. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/psychoanalysis

In his latest book Freud's Pandemics: Surviving Global War, Spanish Flu, and the Nazis (Confer Books, 2021), Professor Brett Kahr has used his remarkable skills as experienced psychotherapist and rigorous historian to tell a meticulously researched, deeply engaging tale of the trials and tribulations of Sigmund Freud's life. Kahr has taken an unflinching look at the darkest hours of this remarkable man, such as the Spanish flu of 1918, the Nazi invasion of Austria in 1938 and a long struggle with carcinoma in later life. Digging deep into the archives, he has unearthed a treasure trove of stories that lets us appreciate Sigmund Freud`s genius even more against the backdrop of his struggle for survival. He has synthesized his findings in elegant prose to offer us an inspiring story of hope, most pertinent for our troubled times. Sebastian Thrul is a psychiatrist and psychoanalyst in training in Germany and Switzerland. He can be reached at sebastian.thrul@gmx.de. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

In his latest book Freud's Pandemics: Surviving Global War, Spanish Flu, and the Nazis (Confer Books, 2021), Professor Brett Kahr has used his remarkable skills as experienced psychotherapist and rigorous historian to tell a meticulously researched, deeply engaging tale of the trials and tribulations of Sigmund Freud's life. Kahr has taken an unflinching look at the darkest hours of this remarkable man, such as the Spanish flu of 1918, the Nazi invasion of Austria in 1938 and a long struggle with carcinoma in later life. Digging deep into the archives, he has unearthed a treasure trove of stories that lets us appreciate Sigmund Freud`s genius even more against the backdrop of his struggle for survival. He has synthesized his findings in elegant prose to offer us an inspiring story of hope, most pertinent for our troubled times. Sebastian Thrul is a psychiatrist and psychoanalyst in training in Germany and Switzerland. He can be reached at sebastian.thrul@gmx.de. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/history

In his latest book Freud's Pandemics: Surviving Global War, Spanish Flu, and the Nazis (Confer Books, 2021), Professor Brett Kahr has used his remarkable skills as experienced psychotherapist and rigorous historian to tell a meticulously researched, deeply engaging tale of the trials and tribulations of Sigmund Freud's life. Kahr has taken an unflinching look at the darkest hours of this remarkable man, such as the Spanish flu of 1918, the Nazi invasion of Austria in 1938 and a long struggle with carcinoma in later life. Digging deep into the archives, he has unearthed a treasure trove of stories that lets us appreciate Sigmund Freud`s genius even more against the backdrop of his struggle for survival. He has synthesized his findings in elegant prose to offer us an inspiring story of hope, most pertinent for our troubled times. Sebastian Thrul is a psychiatrist and psychoanalyst in training in Germany and Switzerland. He can be reached at sebastian.thrul@gmx.de. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/german-studies

In his latest book Freud's Pandemics: Surviving Global War, Spanish Flu, and the Nazis (Confer Books, 2021), Professor Brett Kahr has used his remarkable skills as experienced psychotherapist and rigorous historian to tell a meticulously researched, deeply engaging tale of the trials and tribulations of Sigmund Freud's life. Kahr has taken an unflinching look at the darkest hours of this remarkable man, such as the Spanish flu of 1918, the Nazi invasion of Austria in 1938 and a long struggle with carcinoma in later life. Digging deep into the archives, he has unearthed a treasure trove of stories that lets us appreciate Sigmund Freud`s genius even more against the backdrop of his struggle for survival. He has synthesized his findings in elegant prose to offer us an inspiring story of hope, most pertinent for our troubled times. Sebastian Thrul is a psychiatrist and psychoanalyst in training in Germany and Switzerland. He can be reached at sebastian.thrul@gmx.de. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/jewish-studies

In his latest book Freud's Pandemics: Surviving Global War, Spanish Flu, and the Nazis (Confer Books, 2021), Professor Brett Kahr has used his remarkable skills as experienced psychotherapist and rigorous historian to tell a meticulously researched, deeply engaging tale of the trials and tribulations of Sigmund Freud's life. Kahr has taken an unflinching look at the darkest hours of this remarkable man, such as the Spanish flu of 1918, the Nazi invasion of Austria in 1938 and a long struggle with carcinoma in later life. Digging deep into the archives, he has unearthed a treasure trove of stories that lets us appreciate Sigmund Freud`s genius even more against the backdrop of his struggle for survival. He has synthesized his findings in elegant prose to offer us an inspiring story of hope, most pertinent for our troubled times. Sebastian Thrul is a psychiatrist and psychoanalyst in training in Germany and Switzerland. He can be reached at sebastian.thrul@gmx.de. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/biography

In his latest book Freud's Pandemics: Surviving Global War, Spanish Flu, and the Nazis (Confer Books, 2021), Professor Brett Kahr has used his remarkable skills as experienced psychotherapist and rigorous historian to tell a meticulously researched, deeply engaging tale of the trials and tribulations of Sigmund Freud's life. Kahr has taken an unflinching look at the darkest hours of this remarkable man, such as the Spanish flu of 1918, the Nazi invasion of Austria in 1938 and a long struggle with carcinoma in later life. Digging deep into the archives, he has unearthed a treasure trove of stories that lets us appreciate Sigmund Freud`s genius even more against the backdrop of his struggle for survival. He has synthesized his findings in elegant prose to offer us an inspiring story of hope, most pertinent for our troubled times. Sebastian Thrul is a psychiatrist and psychoanalyst in training in Germany and Switzerland. He can be reached at sebastian.thrul@gmx.de. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/intellectual-history

Você sabia que Sigmund Freud foi anatomista? Por que ele prescreveria cocaína para um amigo? Qual sua relação com Paris? Ficou curioso? Ouça o episódio. Imagem: Ilustração de Alison Bechdel. Kahr, Bret; Bechdel, Alison. Cofee with Freud. London and New York: Routledge, Taylor and Francis Group, 2018. Fontes: BENMOUSSA, Nadia; CHARLIER, Philippe; REBIBO, John‐David. Historical Vignette: Attempted treatment of Sigmund Freud's oral squamous cell carcinoma by vasectomy (Steinach Operation) in 1923. Andrology, v. 8, n. 3, p. 688-690, 2020. FREUD, Sigmund et al. The origins of psycho-analysis: Letters to Wilhelm Fliess, drafts and notes: 1887-1902. 1954. FREUD, Sigmund; MEURER, Jose Luis. Publicações pré-psicanalíticas e esboços inéditos. Imago, 1990. HARDT JR, Orlando. Dezenove semanas em Paris. Jornal de Psicanálise, v. 51, n. 95, p. 213-228, 2018. MARKEL, Howard. An anatomy of addiction: Sigmund Freud, William Halsted, and the miracle drug cocaine. Vintage Books, 2012. SCHUR, Max. Freud: Living and dying. 1972. --- Send in a voice message: https://anchor.fm/jordanoaraujo/message

Thành phố lớn thứ hai của Áo từ hai tuần nay do một người cộng sản lãnh đạo. Thắng lợi trong cuộc bầu cử của bà Elke Kahr ở Graz đã gây chấn động dư luận quốc tế. Theo bà, thành công của mình là một tín hiệu cho thấy sự củng cố nói chung của lý tưởng xã hội chủ nghĩa ở châu Âu. Xem thêm: http://nghiencuuquocte.org/2021/12/10/elke-kahr-thi-truong-cong-san-dau-tien-tai-ao/

To get live links to the music we play and resources we offer, visit This show includes the following songs: Marie  Chabot - Let it Snow! Let it Snow Carolyn Barela - We Three Kings, Carol of The Bells Shawn Thies - Angels We Have Heard on High Joy Zimmerman - Gift Of Light Kim Krenik feat. Bethany, Lucas & Keira Krenik - The Gift   Perpetual Motion - Silent Night Lynn Carey Saylor - Spirit Of Love Jules Emerald Anderson - Wrap My Christmas (with a Dream) Doro Streich & Ira Diehr (writer Jim Kahr) - It's That Time Of Year Beloved Heartsong - Away In The Manger Ms. Maura & The Misters - Snowmen In LA For Music Biz Resources Visit Visit our Sponsor Jules Emerald Anderson at: Visit our Sponsor the Bluestone Sisters at: Visit our Sponsor Shaun Murphy Band at:

To get live links to the music we play and resources we offer, visit This show includes the following songs: Marie  Chabot - Let it Snow! Let it Snow Carolyn Barela - We Three Kings, Carol of The Bells Shawn Thies - Angels We Have Heard on High Joy Zimmerman - Gift Of Light Kim Krenik feat. Bethany, Lucas & Keira Krenik - The Gift   Perpetual Motion - Silent Night Lynn Carey Saylor - Spirit Of Love Jules Emerald Anderson - Wrap My Christmas (with a Dream) Doro Streich & Ira Diehr (writer Jim Kahr) - It's That Time Of Year Beloved Heartsong - Away In The Manger Ms. Maura & The Misters - Snowmen In LA For Music Biz Resources Visit Visit our Sponsor Jules Emerald Anderson at: Visit our Sponsor the Bluestone Sisters at: Visit our Sponsor Shaun Murphy Band at:

This week, I'm joined by TJ and Weerd Beard to discuss the Kahr brand of handguns and my new 9mm single-stack! Visit www.handgunradio.com for complete show notes!

NYPD blames Kahr firearm for the abysmal training officers receive,Pistol whip a child and all bets are off, Avery good and entertaining conversation with Edwin Walker and Michelle Byington of Texas/US Law Shield.